Intranasal Parainfluenza Virus Type 5- SARS CoV-2 S Vaccine (CyanVac)

N/A

Report date: 2024/07/02 16:38:29

Base Information

Drug NameIntranasal Parainfluenza Virus Type 5- SARS CoV-2 S Vaccine (CyanVac)
Drug Alias NameIntranasal PIV5 COVID-19 Vaccine (CyanVac)CVXGAPIV5-SARS CoV-2 vaccineCVXGA-1BLB-101
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCyanVac Llc
China Registration ClassN/A

Develop Information

Active CompaniesCyanVac Llc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A